Moderna, Rovi ink 10-year contract extension for production of COVID and future vaccinesnews2022-02-17T12:47:32+00:00February 17th, 2022|Fierce Pharma|
Moderna swings into expansion mode, adding 6 European countries to its commercial empirenews2022-02-17T11:38:04+00:00February 17th, 2022|Fierce Pharma|
Eliquis partners BMS, Pfizer double down on heart health with renewed ‘No Time to Wait’ campaignnews2022-02-17T09:56:36+00:00February 17th, 2022|Fierce Pharma|
Argenx’s Vygart launch finds quick neurologist support over AstraZeneca’s well-entrenched Soliris for myasthenia gravisnews2022-02-17T09:37:06+00:00February 17th, 2022|Fierce Pharma|
Argenx’s Vyvgart launch finds quick neurologist support over AstraZeneca’s well-entrenched Soliris for myasthenia gravisnews2022-02-17T09:37:06+00:00February 17th, 2022|Fierce Pharma|
3 more deaths among patients on Biogen’s Aduhelm fuel safety concerns, though no link established: analystnews2022-02-16T23:15:40+00:00February 16th, 2022|Fierce Pharma|
Lilly’s tirzepatide doesn’t necessarily top diabetes rivals Jardiance and Ozempic, ICER saysnews2022-02-16T16:57:39+00:00February 16th, 2022|Fierce Pharma|
As Johnson & Johnson fights for bankruptcy ploy in talc litigation, Congress is weighing innews2022-02-16T16:36:23+00:00February 16th, 2022|Fierce Pharma|
After FDA’s surprising about-face, Acadia revives Nuplazid’s expansion bid with narrower Alzheimer’s focusnews2022-02-16T16:30:52+00:00February 16th, 2022|Fierce Pharma|
BioNTech to ship modular mRNA factories to Africa starting this yearnews2022-02-16T15:06:59+00:00February 16th, 2022|Fierce Pharma|
